BROOKFIELD, Wis.--(BUSINESS WIRE)--Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, and Akoya, an API-only network for the consumer-permissioned ...

There is a great battle being waged on your behalf and chances are you don’t even know it. Every day millions of people transact online, in stores, and in mobile apps. All that detail of who, how much ...

After biotech firm Akoya Biosciences previously announced it would be acquired by Billerica-based research corporation Quanterix, the Marlborough-based company is now considering an unsolicited, ...

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer. The unsolicited offer came May 21 after Akoya had ...

Fiserv Inc. is working with data aggregator Akoya LLC to enable consumers to share their financial data with fintech and third-parties with which they do business in a way that doesn’t expose a ...

PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies. PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in ...

Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration ...

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

BOSTON--(BUSINESS WIRE)--Akoya, a 100% API-connected data access network, announced today an agreement with leading data access platform Envestnet | Yodlee, to help consumers more efficiently manage ...

Akoya Biosciences makes single-cell imaging solutions to aid in phenotyping cells. The company is not profitable. Akoya's shares hit a 52-week low on June 8. Akoya executives purchased just more than ...